Allied Academies Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).
Allied Academies invites all the participants from all over the world to attend "11th International Conference on Cancer Stem Cells and Oncology Research”, on June 11-13, 2018 in Dublin, Ireland which includes prompt keynote presentations, oral talks, poster presentations and exhibitions.
Cancer stem cells (CSCs) are cancer cells (found within tumors or haematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumour-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.
Cancer Stem Cells 2018 is a platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Cancer Stem Cells 2018 will have an anticipated participation of 120+ delegates across the world to discuss the conference goal.
Allied Academies is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia. Allied Academics has so far organized 3000+ Global Allied Academics Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology.
Cancer Stem Cells 2018 will encompass recent researches and findings in Cancer stem cells technologies, Cancer stem cells therapies and transplantations, current understanding of cell plasticity in cancer and other advancements in Cancer stem cells research and cell science. Cancer Stem Cells 2018 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Cancer Stem Cells 2018 will focus on the latest and exciting innovations in prominent areas of Cancer cell science and Cancer stem cells research.
Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations Heads and Professors, Research scientists, Cancer Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Cancer Stem cells research can be as Target Audience.